Taro Pharmaceutical
TARO
#5312
Rank
HK$12.66 B
Marketcap
HK$336.95
Share price
0.00%
Change (1 day)
9.08%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): HK$4.78

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$9.57. In 2021 the company made an earnings per share (EPS) of HK$0.31 an increase over its 2020 EPS that were of -HK$62.03.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$4.78
2021HK$0.31-100.51%
2020-HK$62.03-222.45%
2019HK$50.66-18.02%
2018HK$61.7953.01%
2017HK$40.38-55.95%
2016HK$91.67-13.41%
2015HK$105.8636.92%
2014HK$77.3237.71%
2013HK$56.1421.15%
2012HK$46.3444.15%
2011HK$32.15175.17%
2010HK$11.68-48.8%
2009HK$22.82
2005HK$0.24-91.89%
2004HK$2.90-82.55%
2003HK$16.6235.9%
2002HK$12.2339.29%
2001HK$8.78140.86%
2000HK$3.6569.09%
1999HK$2.16139.13%
1998HK$0.9064.29%
1997HK$0.55-36.36%
1996HK$0.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42 447.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.17 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-37.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.94-48.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel